CFM Wealth Partners LLC Acquires 451 Shares of Procter & Gamble Company (The) $PG

CFM Wealth Partners LLC raised its holdings in Procter & Gamble Company (The) (NYSE:PG) by 4.5% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 10,524 shares of the company’s stock after acquiring an additional 451 shares during the quarter. CFM Wealth Partners LLC’s holdings in Procter & Gamble were worth $1,677,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Nova Wealth Management Inc. acquired a new position in Procter & Gamble during the 1st quarter worth about $26,000. Signature Resources Capital Management LLC increased its stake in shares of Procter & Gamble by 67.9% in the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock valued at $28,000 after buying an additional 72 shares during the period. Quarry LP bought a new position in shares of Procter & Gamble during the first quarter worth about $33,000. Mizuho Securities Co. Ltd. lifted its stake in shares of Procter & Gamble by 566.7% in the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock worth $34,000 after acquiring an additional 170 shares during the period. Finally, RMG Wealth Management LLC bought a new stake in Procter & Gamble in the second quarter valued at approximately $37,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Buying and Selling

In related news, CEO Jon R. Moeller sold 40,119 shares of Procter & Gamble stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $6,309,515.13. Following the completion of the sale, the chief executive officer owned 319,375 shares of the company’s stock, valued at approximately $50,228,106.25. This trade represents a 11.16% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Andre Schulten sold 11,638 shares of the firm’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the transaction, the chief financial officer directly owned 52,642 shares in the company, valued at $8,279,007.34. This trade represents a 18.11% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 149,763 shares of company stock worth $23,421,279 over the last quarter. Corporate insiders own 0.20% of the company’s stock.

Procter & Gamble Stock Performance

Shares of PG opened at $150.47 on Tuesday. Procter & Gamble Company has a one year low of $149.91 and a one year high of $180.43. The company has a market cap of $352.17 billion, a PE ratio of 23.11, a P/E/G ratio of 4.02 and a beta of 0.36. The stock has a 50-day moving average of $155.38 and a 200-day moving average of $159.84. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same period in the prior year, the business earned $1.40 EPS. The firm’s revenue for the quarter was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities research analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on PG. Barclays dropped their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Evercore ISI reaffirmed an “in-line” rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. UBS Group set a $180.00 price objective on Procter & Gamble and gave the stock a “buy” rating in a research report on Wednesday, July 30th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $170.00 price objective (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Finally, Wells Fargo & Company decreased their target price on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. Eleven research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $173.11.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.